Here at Oricell Therapeutics
关于我们
Founded in 2015, OriCell Therapeutics aims to develop drugs with good efficacy and affordable prices to satisfy the globally unmet clinical needs through innovations and strives to become the world-leading developer of novel drugs for tumor immunotherapy.
- 网站
-
https://www.oricell.com/en/
Oricell Therapeutics Co., Ltd.的外部链接
- 所属行业
- 生物技术
- 规模
- 51-200 人
- 总部
- Shanghai
- 类型
- 合营企业
地点
-
主要
获取路线
1227 Zhangheng Rd
Third Floor, Building #1
CN，Shanghai
Oricell Therapeutics Co., Ltd.员工
动态
-
First IND clearance of OriCAR-017 by FDA. We are excited to initiate the Ph1 trial among r/r MM patients with this great product. Patients worldwide deserve a better and safer CAR-T product.
Oricell GPRC5D CAR-T Therapy Clears FDA IND Hurdle, Paving the Way for Global Impact
Oricell Announces FDA Clearance of IND Application for OriCAR-017, a novel GPRC5D Targeted CAR-T Cell for the treatment of RRMM
Oricell Therapeutics Co., Ltd.，发布于领英
-
Oricell GPRC5D CAR-T Therapy Clears FDA IND Hurdle, Paving the Way for Global Impact
Oricell Announces FDA Clearance of IND Application for OriCAR-017, a novel GPRC5D Targeted CAR-T Cell for the treatment of RRMM
Oricell Therapeutics Co., Ltd.，发布于领英
-
Oricell Therapeutics to Showcase Latest Advancements in Cell Therapies for Oncology at 42nd JP Morgan Healthcare Conference Shanghai, China, and New Jersey, USA – January 1, 2024: Oricell Therapeutics (“Oricell” or the "Company"), a global clinical-stage biopharmaceutical firm dedicated to innovative cell therapies for oncology, is set to make its presence felt at the 42nd Annual JP Morgan Healthcare Conference. Co-founder & Chief Executive Officer, Ms. Helen Yang, and co-founder & Chief Scientific Officer, Dr. Peter He, will jointly participate in the conference. During the event, we will share insights on the company's latest advancements in the field. Presentation Date: January 10, 2024. Presentation Time: 4:00 pm - 4:25 pm Pacific time. Presentation Venue: San Francisco Marriott Marquis Golden Gate.
-